Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression

PURPOSE: Gemcitabine is currently the standard first-line chemotherapeutic drug for treating pancreatic cancer. However, many factors can contribute to gemcitabine resistance. One of the most important reasons is the low hENT1 expression. In this study, we tested the antitumor effect of gemcitabine-...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Nanomedicine
Hlavní autoři: Guo, Zhongyi, Wang, Feng, Di, Yang, Yao, Lie, Yu, Xinzhe, Fu, Deliang, Li, Ji, Jin, Chen
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6122898/
https://ncbi.nlm.nih.gov/pubmed/30214194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S166769
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky